Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biden Admin Pays Ellume $231M To Build COVID-19 US Test Plant

Feb 01 2021

The Biden administration has given Ellume $213.8M to build a factory in the US to produce their at-home OTC COVID-19 test. — • Source: Shutterstock/ Ellume Health (Shutterstock)

Related Content

First COVID-19 At-Home Test That Doesn’t Require A Prescription Authorized By The FDA

Dec 15 2020

Senate Passes Fourth COVID-19 Spending Package, Includes $25Bn For Additional Testing, Contact Tracing

Apr 22 2020

Additional Topics

United States Policy Research & Development Commercial Companies Coronavirus COVID-19 Deals Innovation Legislation Manufacturing Strategy Consumer Infectious Diseases Diagnostics In Vitro Diagnostics Medical Device

More from R&D

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window